ArticleCell death & disease2017

miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.

Xiaofeng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.